SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-21-002073
Filing Date
2021-01-05
Accepted
2021-01-05 17:26:31
Documents
3
Group Members
ARTAL GROUP S.A.ARTAL INTERNATIONAL MANAGEMENT S.A.ARTAL INTERNATIONAL S.C.A.ARTAL TREASURY LTDINVUS ADVISORS, L.L.C.INVUS PARTNERS, LLCINVUS PUBLIC EQUITIES ADVISORS, LLCINVUS PUBLIC EQUITIES, L.P.MR. PASCAL MINNEMR. RAYMOND DEBBANESTICHTING ADMINISTRATI

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 16 TO SCHEDULE 13D d228342dsc13da.htm SC 13D/A 247174
2 EXHIBIT 20 d228342dex9920.htm EX-99.20 18834
3 EXHIBIT 21 d228342dex9921.htm EX-99.21 4557
  Complete submission text file 0001193125-21-002073.txt   272782
Mailing Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381
Business Address 8800 TECHNOLOGY FOREST PLACE THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Subject) CIK: 0001062822 (see all company filings)

IRS No.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-60409 | Film No.: 21507270
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022
Business Address C/O THE INVUS GROUP, LLC 750 LEXINGTON AVENUE, 30TH FLOOR NEW YORK NY 10022 (212) 371-1717
Invus, L.P. (Filed by) CIK: 0001404570 (see all company filings)

IRS No.: 830359143
Type: SC 13D/A